Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

1,181 questions · 1,197 findings · 144 reviews

No studies found 196 · 16.4%GRADE not reported 213 · 17.8%Very low 274 · 22.9%Low 296 · 24.7%Moderate 171 · 14.3%High 47 · 3.9%

CLOZAPINE + RISPERIDONE vs CLOZAPINE + ZIPRASIDONE (Kuwilsky 2010)

Quality of life/satisfaction with care for either recipients of care or carers: significant change in quality of life/satisfaction · people with treatment‐resistant schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

CLOZAPINE + ZIPRASIDONE vs CLOZAPINE + QUETIAPINE (Wen 2015)

Clinical response: no clinically significant response in mental state: ≥ 50% reduction in PANSS total score Medium term (12 weeks) · people with treatment‐resistant schizophrenia

CLOZAPINE + ZIPRASIDONE may leads to lower clinical response: no clinically significant response in mental… compared with CLOZAPINE + QUETIAPINE (Wen 2015) (low certainty).

1 finding from 1 review

CLOZAPINE + ZIPRASIDONE vs CLOZAPINE + QUETIAPINE (Wen 2015)

Quality of life/satisfaction with care for either recipients of care or carers: significant change in quality of life/satisfaction · people with treatment‐resistant schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

CLOZAPINE + ARIPIPRAZOLE vs CLOZAPINE + HALOPERIDOL (Cipriani 2013)

Quality of life/satisfaction with care for either recipients of care or carers: significant change in quality of life/satisfaction · people with treatment‐resistant schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Pain freedom at 2 h · acute treatment of migraine in children

The intervention led to higher pain freedom at 2 h; GRADE not reported.

1 finding from 1 review

Intervention not reported

Pain freedom at 2 h · acute treatment of migraine in children

The intervention probably leads to higher pain freedom at 2 h (moderate certainty).

1 finding from 1 review

Intervention not reported

Pain freedom at 2 h · acute treatment of migraine in adolescents

The intervention probably leads to higher pain freedom at 2 h (moderate certainty).

1 finding from 1 review

Intervention not reported

Adverse events · acute treatment of migraine in adolescents

The intervention probably leads to higher adverse events (moderate certainty).

1 finding from 1 review

Intervention not reported

Pain freedom at 2 h · acute treatment of migraine in adolescents

The intervention probably leads to higher pain freedom at 2 h (moderate certainty).

1 finding from 1 review